Pasar al contenido principal

DESCIFRANDO EL POTENCIAL DE LOX Y DE LA PROTEINA MATRICELULAR TSP4 COMO NUEVAS DIANAS TERAPEUTICAS EN LA ATEROSCLEROSIS Y EL ANEURISMA DE AORTA ABDOMINAL.

PI21/01048

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2021
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO
Centro realización IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of endoplasmic reticulum stress-associated lncRNAs influencing inflammation and VSMC function in abdominal aortic aneurysm

  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Sánchez-Infantes, David|||0000-0001-6086-7501
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Cáncer, Susana
  • Pérez-Marlasca, Elvira|||0000-0001-9815-198X
  • Medina-Gómez, Gema|||0000-0001-8169-681X
  • Martínez-González, José|||0000-0002-3894-7166
  • Garcia Redondo, Ana B.|||0000-0002-5815-3320
  • Galán, María|||0000-0002-4758-8388
Endoplasmic reticulum (ER) stress plays a critical role in the abdominal aortic aneurysm (AAA), a life-threatening disease characterized by inflammation, destructive remodeling, and vascular smooth muscle cells (VSMCs) dysfunction. The current therapy relies on surgical repair, but no effective pharmacological strategies are available to limit aneurysm progression. Long non-coding RNAs (lncRNAs) are essential factors in health and disease; however, their specific contribution to AAA development and its relationship with ER stress remain unexplored. Here, we have performed a whole-genome transcriptomic analysis characterizing the expression profile of lncRNAs in AAA. RNA sequencing was carried out in abdominal aorta from patients with AAA and healthy donors. We identified 6576 differentially expressed (DE)-mRNAs and 1283 DE-lncRNAs. Interestingly, bioinformatic analysis revealed a set of 368 DE-lncRNAs related to ER stress. The differential expression of the most induced lncRNAs (IL-21-AS1, ITPKB-IT, PCED1B-AS1, TCL-6, LINC00494, LINC00582, LINC00626, LINC00861, and LINC00892) was validated in a large cohort of patients with AAA. The ability of these selected lncRNAs to discriminate patients with AAA from healthy subjects was established by receiveroperating characteristic curves and logistic regression analysis. In human aortic VSMC and Jurkat T-cells, tunicamycin-induced ER stress triggered the expression of IL21-AS1, LINC00626, LINC00494, LINC00892, PCED1B-AS1, ITPKB-IT, and TCL-6, while tauroursodeoxycholic acid counteracted these effects. Finally, an integrated analysis of mRNA-lncRNA co-expression revealed the correlation between the selected lncRNAs and the DE-mRNAs involved in immune response and muscle contraction. Therefore, these DE-lncRNAs potentially implicated in the ER stress response, a pathological process in AAA, could be considered as potential therapeutic target to handle AAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identificación de nuevas dianas terapéuticas relacionadas con el estrés del retículo endoplasmático y con la disfunción mitocondrial para reducir el riesgo de rotura en el aneurisma de aorta ascendente degenerativo, Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm

  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Barros-Membrilla, Antonio J.|||0000-0003-4053-2821
  • Pérez-Marlasca, Elvira|||0000-0001-9815-198X
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Martinez-González, José
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Galán, María|||0000-0002-4758-8388
Antecedentes: El aneurisma de aorta torácica ascendente (AATA) es una dilatación progresiva de la aorta que puede complicarse con su disección causando la muerte del 80-90 % de los pacientes. Cuando se asocia con el envejecimiento y la aterosclerosis, su pronóstico es peor siendo la cirugía reconstructiva la única terapia disponible. Nuestro objetivo es caracterizar el perfil de genes expresados diferencialmente (GED) implicados en el estrés del retículo endoplásmico y la disfunción mitocondrial en pacientes con AATA degenerativo. Métodos: mediante secuenciación de ARN utilizando ARN extraído de AATA de pacientes degenerativos (n=13) y donantes multiorgánicos sanos (n=6) identificamos GED relacionados con el estrés del RE y la disfunción mitocondrial con el paquete DESeq2. El análisis de vías enriquecidas (Reactome) y de interacción de proteínas se realizó con el paquete clusterProfiles y se analizó con la base de datos String y el software Cytoscape. Resultados: la histología reveló una desorganización completa de la matriz extracelular y pérdida celular en la pared aórtica de los pacientes donde detectamos una regulación positiva de 15 GED y negativa de 13 GED relacionados con el estrés del RE (ATF4, EIF2AK3, HSPA5, ERN1, SEL1L), la disfunción mitocondrial (DNML1, IMMT, MT-CO3, MT-CYB, MT ND2, TIMM17B, MT-ERF1, TOMM5) y la remodelación de la matriz extracelular. Los resultados del análisis del término GO y de las vías enriquecidas confirmaron la relación de estos GED con enfermedades de la aorta. Conclusiones: Nuestros datos demuestran que las proteínas relacionadas con la disfunción mitocondrial y el estrés del RE podrían postularse como dianas terapéuticas para tratar el AATA., Background: Ascending Thoracic Aortic Aneurysm (ATAA) is a progressive dilation of the aorta that can be complicated by its dissection leading to death in 80-90% of the patients. When associated with aging and atherosclerosis, the outcome is worse and reconstructive surgery is the only effective therapy. Our objective was to characterize differential expressed genes (DEG) involved in endoplasmic reticulum (ER) and mitochondria dysfunction in patients with degenerative ATAA. Methods: A transcriptomic analysis was performed by RNA sequencing using RNA isolated from ATAA of patients classified as degenerative (n = 13) and multi-organ healthy donors (n = 6). DEGs related to ER stress and mitochondrial dysfunction were identified with the DESeq2 package. Enriched pathway (Reactome) and protein interaction (PPI) analysis was performed with the clusterProfiles package. PPI of the selected DEGs was analyzed based on the string database and visualized by Cytoscape software. Results: Histology revealed a complete disorganization of the extracellular matrix (ECM) and cell loss in the aortic wall of ATAA patients where the upregulation of 15 DEGs and the downregulation of 13 DEGs that encode proteins related to ER stress (ATF4, EIF2AK3, HSPA5, ERN1, SEL1L), mitochondrial dysfunction (DNML1, IMMT, MT-CO3, MT-CYB, MT ND2, TIMM17B, MT-ERF1, TOMM5) and ECM was detected. The results of GO term and enriched pathway analysis indicated that these DEGs are mainly enriched in pathways related to aortic diseases. Conclusions: Our data show that proteins related to mitochondrial dysfunction and ER stress might be therapeutic targets for the treatment of ATAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inhibition of ATP-citrate lyase by bempedoic acid protects against abdominal aortic aneurysm formation in mice

  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Galán, María|||0000-0002-4758-8388
  • Roglans, Nuria
  • Laguna, Joan Carles|||0000-0002-2357-1186
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Blanco-Casoliva, Laia
Abdominal aortic aneurysm (AAA) is a prevalent degenerative disease characterized by an exacerbated inflammation and destructive vascular remodeling. Unfortunately, effective pharmacological tools for the treatment of this disease remain a challenge. ATP-citrate lyase (ACLY), the primary enzyme responsible for acetyl-CoA biosynthesis, is a key regulator of inflammatory signaling in macrophages and lymphocytes. Here, we found increased levels of the active (phosphorylated) form of ACLY (p-ACLY) in the inflammatory infiltrate of AAA from patients and in aneurysmal lesions from angiotensin II (Ang II)-infused apolipoprotein E-deficient mice (ApoE). Furthermore, plasma ACLY levels positively correlates with IL6 and IFNγ levels in patients with AAA, while inflammatory stimuli strongly upregulated ACLY expression in macrophages and Jurkat cells. The administration of the ACLY inhibitor bempedoic acid (BemA) protected against Ang II-induced AAA formation in ApoE mice, limiting the progression of aortic dilatation and reducing mortality due to aortic rupture. BMS-303141, another ACLY inhibitor, also ameliorated AAA formation, although to a lesser extent. BemA attenuated vascular remodeling and the disorganization and rupture of elastic fibers induced by Ang II, as well as vascular inflammation, decreasing the recruitment of macrophages (CD68 +) and neutrophils (Ly-6G+) into the aortic wall. Moreover, BemA shifted splenic monocytes toward a functionally anti-inflammatory phenotype, and increased the percentage of CD4CD69 cells. Taken together, these results support the contribution of ACLY to AAA and point to BemA as a promising tool to be considered for future clinical trials addressing the management of this disease which is quite often associated with disorders of lipoprotein metabolism.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel pharmacological approaches in abdominal aortic aneurysm

  • Puertas-Umbert, Lídia
  • Almendra-Pegueros, Rafael
  • Jiménez-Altayó, Francesc
  • Sirvent, Marc
  • Galán, María
  • Martínez-González, José
  • Rodríguez-Sinovas, Cristina
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health issue with an unmet medical need for therapy. This disease is featured by a progressive dilation of the abdominal aorta, boosted by atherosclerosis, ageing, and smoking as major risk factors. Aneurysm growth increases the risk of aortic rupture, a life-threatening emergency with high mortality rates. Despite the increasing progress in our knowledge about the etiopathology of AAA, an effective pharmacological treatment against this disorder remains elusive and surgical repair is still the unique available therapeutic approach for high-risk patients. Meanwhile, there is no medical alternative for patients with small aneurysms but close surveillance. Clinical trials assessing the efficacy of antihypertensive agents, statins, doxycycline, or anti-platelet drugs, among others, failed to demonstrate a clear benefit limiting AAA growth, while data from ongoing clinical trials addressing the benefit of metformin on aneurysm progression are eagerly awaited. Recent preclinical studies have postulated new therapeutic targets and pharmacological strategies paving the way for the implementation of future clinical studies exploring these novel therapeutic strategies. This review summarises some of the most relevant clinical and preclinical studies in search of new therapeutic approaches for AAA., This research was funded by the Spanish Ministerio de Ciencia e Innovación (PID2021-122509OB-I00) [grant number MCIN/ AEI/10.13039/501100011033]; “ERDF A way of making Europe”; Instituto de Salud Carlos III (ISCIII) [grants numbers PI21/01048 and PI20/01649]; Fundación Española de Arteriosclerosis-Sociedad Española de Arteriosclerosis (Beca de Investigación Básica 2020); and Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. L.P-U. and R.A.-P are supported by a PFIS fellowship (ISCIII)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeting mitochondrial stress with Szeto-Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stress

  • Navas-Madroñal, Miquel
  • Almendra-Pegueros, Rafael
  • Puertas-Umbert, Lídia
  • Jiménez-Altayó, Francesc
  • Julve, Josep
  • Pérez, Belén
  • Consegal-Pérez, Marta
  • Kassan, Modar
  • Martínez-González, José
  • Rodríguez-Sinovas, Cristina
  • Galán, María
Mitochondrial dysfunction and inflammation contribute to a myriad of cardiovascular diseases. Deleterious crosstalk of mitochondria and persistent endoplasmic reticulum (ER) stress triggers oxidative stress, which is involved in the development of vascular diseases. This study determined if inhibition of mitochondrial stress reduces aneurysm development in angiotensin II (Ang II)-infused apolipoprotein-E-deficient (ApoE-/- ) mice and its effect on ER stress., This work was funded by grants from the Instituto de Salud Carlos III (ISCIII) (grants PI17/01837 and PI20/01004 to M.G. and PI21/01048 to C.R.). M.N.-M. was supported by a contract associated to a Miguel Servet project (CP15/00126). R.A.-P. and L.P.-U. are supported by a PFIS fellowship (FI21/00125 and FI19/00331, respectively; ISCIII). M.G. was hired under the Miguel Servet Programme (ISCIII; Refs CP15/00126 and CP20/01004), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress

  • Ballester-Servera, Carme
  • Alonso, Judith
  • Cañes, Laia
  • Vázquez-Sufuentes, Paula
  • García-Redondo, Ana B.
  • Rodríguez, Cristina
  • Martínez-González, José
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)., Lysyl oxidase (LOX)-mediated extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease; however, this enzyme also induces oxidative stress. We addressed the contribution of LOX-dependent oxidative stress to cardiovascular calcification. LOX is upregulated in human-calcified atherosclerotic lesions and atheromas from atherosclerosis-challenged LOX transgenic mice (TgLOXVSMC) and colocalized with a marker of oxidative stress (8-oxo-deoxyguanosine) in vascular smooth muscle cells (VSMCs). Similarly, in calcific aortic valves, high LOX expression was detected in valvular interstitial cells (VICs) positive for 8-oxo-deoxyguanosine, while LOX and LOXL2 expression correlated with osteogenic markers (SPP1 and RUNX2) and NOX2. In human VICs, mito-TEMPO and TEMPOL attenuated the increase in superoxide anion levels and the mineralization induced by osteogenic media (OM). Likewise, in OM-exposed VICs, β-aminopropionitrile (a LOX inhibitor) ameliorated both oxidative stress and calcification. Gain- and loss-of-function approaches in VICs demonstrated that while LOX silencing negatively modulates oxidative stress and calcification induced by OM, lentiviral LOX overexpression exacerbated oxidative stress and VIC calcification, effects that were prevented by mito-TEMPO, TEMPOL, and β-aminopropionitrile. Our data indicate that LOX-induced oxidative stress participates in the procalcifying effects of LOX activity in ectopic cardiovascular calcification, and highlight the multifaceted role played by LOX isoenzymes in cardiovascular diseases., This work was supported by the Spanish Ministerio de Ciencia e Innovación (RTI2018-094727-B-100 and PID2021-122509OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”), and Instituto de Salud Carlos III (ISCIII; Spain; PI21/01048). C.B-S was supported by a FPU fellowship (FPU19/05257; Ministerio de Universidades; Spain) and P.V.-S by a FPI fellowhip (PRE2022-103796; Ministerio de Ciencia e Innovación; Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Análisis de vías y genes implicados en la dilatación temprana del aneurisma de aorta abdominal en el modelo de animal transgénico de NOR-1

  • Vázquez-Sufuentes, Paula
  • Ballester-Servera, Carme
  • Martín Fernández, L.
  • Comes, N.
  • Alonso, Judith
  • Borrás, Nina
  • Corrales, Irene
  • Vidal, Francisco
  • Rodríguez-Sinovas, Cristina
  • Martínez-González, José
Trabajo presentado en el XXXVI Congreso de la Sociedad Española de Arteriosclerosis, celebrado en Castellón (España) del 12 al 14 de junio de 2024, Introducción: El aneurisma de aorta abdominal (AAA) es una enfermedad con una elevada morbimortalidad, caracterizada por la progresiva dilatación de la aorta que puede culminar en su rotura. El receptor nuclear NOR-1 participa en el desarrollo del AAA, tanto en pacientes como en modelos experimentales. Objetivo: Identificar genes regulados por NOR-1 implicados en AAA. Materiales y métodos: Se implantaron minibombas de infusión de angiotensina II (1000 ng/kg/min) a ratones transgénicos que sobreexpresan NOR-1 en células musculares lisas vasculares (TgNOR-1VSMC) y a controles, y se analizó el diámetro de la aorta mediante ecografía (VisualSonics Vevo 2100). Se extrajo RNA de las aortas de los animales que experimentaron dilatación temprana (incremento 25-40% en 4-7 días). Se determinaron los cambios en el transcriptoma mediante secuenciación del RNA (Illumina Stranded mRNA Prep) y se analizaron las vías enriquecidas (GSEA y ORA) usando la base de datos Gene Ontology mediante la herramienta WebGestalt. Los genes más relevantes se validaron por PCR, se clonaron sus promotores y se estudió su regulación mediante la transfección transitoria de construcciones reporteras de luciferasa. Resultados. La secuenciación de RNA mostró una expresión diferencial significativa de 334 genes de los cuales 145 presentaron un Fold-Change >1,5. El análisis bioinformático de vías enriquecidas destacó dos poblaciones funcionales bien diferenciadas: genes de vías inflamatorias y genes implicados en contracción/diferenciación muscular. Mediante PCR a tiempo real se confirmó la inducción de dichos genes y, mediante el análisis de la actividad transcripcional con construcciones de la región promotora proximal, la implicación de NOR-1 en su regulación. Conclusiones. NOR-1 regula la expresión de genes implicados en inflamación y en la transformación fenotípica que experimentan las CMLVs en las primeras fases de la dilatación aórtica que conduce a la formación del AAA., Proyectos PID2021-122509OB-I00 financiado por MCIN/AEI/10.13039/501100011033, FEDER Una manera de hacer Europa y por ISCIII (PI21/01048).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Papel del estrés oxidativo derivado de la actividad LOX en la calcificación cardiovascular

  • Ballester-Servera, Carme
  • Alonso, Judith
  • Cañes, Laia
  • Vázquez-Sufuentes, Paula
  • García-Redondo, Ana B.
  • Rodríguez, Cristina
  • Martínez-González, José
Trabajo presentado en el XXXVI Congreso de la Sociedad Española de Arteriosclerosis, celebrado en Castellón (España) del 12 al 14 de junio de 2024, Introducción: El remodelado de la matriz extracelular (MEX) y el estrés oxidativo juegan un papel importante en la calcificación cardiovascular. La lisil oxidasa (LOX), enzima que participa en la maduración de la MEX y contribuye al estrés oxidativo, se ha implicado en la calcificación de las células musculares lisas vasculares (CMLVs). Objetivo: Analizar la contribución de las especies reactivas de oxigeno (ROS) derivadas de la actividad LOX en la calcificación cardiovascular. Materiales y métodos: Se utilizaron arterias humanas con lesión aterosclerótica y válvulas aórticas calcificadas. Se realizaron estrategias de ganancia o pérdida de función LOX en células intersticiales valvulares (VICs) expuestas a medio osteogénico (OM). Se indujo aterosclerosis en ratones transgénicos que sobreexpresan LOX en CMLVs (TgLOXCMLV) administrando virus adenoasociados AAV-PCSK9D374Y y dieta aterogénica. Resultados: LOX está aumentada tanto en lesiones ateroscleróticas humanas calcificadas como en placas ateroscleróticas de ratones TgLOXCMLV y colocaliza con un marcador de estrés oxidativo (8-oxo-deoxiguanosina) en CMLVs positivas para RUNX2. Asimismo, válvulas aórticas humanas calcificadas mostraron una mayor expresión de LOX en VICs positivas para 8-oxo-deoxiguanosina y RUNX2. La expresión de LOX y LOXL2 correlacionó positivamente con marcadores osteogénicos (RUNX2 y SPP1) y NOX2. VICs expuestas a OM mostraron mayores niveles de ROS y mayor mineralización de la MEX, efectos que fueron atenuados por los antioxidantes mito-TEMPO y TEMPOL y por BAPN (inhibidor de la actividad LOX). El silenciamiento de LOX en VICs moduló negativamente el estrés oxidativo y la mineralización de la MEX mientras que la sobreexpresión de LOX exacerbó los niveles de ROS y la calcificación, efectos que fueron prevenidos por mito-TEMPO, TEMPOL y BAPN. Conclusión: El estrés oxidativo derivado de la actividad LOX contribuye al efecto potenciador de la calcificación cardiovascular ectópica asociado a esta enzima., Proyectos PID2021-122509OB-I00 financiado por MCIN/AEI/10.13039/501100011033 y FEDER Una manera de hacer Europa y PI21/01048-ISCIII
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel pharmacological approaches in abdominal aortic aneurysm

  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
  • Sirvent, Marc|||0000-0001-5912-8760
  • Galán, María|||0000-0002-4758-8388
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health issue with an unmet medical need for therapy. This disease is featured by a progressive dilation of the abdominal aorta, boosted by atherosclerosis, ageing, and smoking as major risk factors. Aneurysm growth increases the risk of aortic rupture, a life-threatening emergency with high mortality rates. Despite the increasing progress in our knowledge about the etiopathology of AAA, an effective pharmacological treatment against this disorder remains elusive and surgical repair is still the unique available therapeutic approach for high-risk patients. Meanwhile, there is no medical alternative for patients with small aneurysms but close surveillance. Clinical trials assessing the efficacy of antihypertensive agents, statins, doxycycline, or anti-platelet drugs, among others, failed to demonstrate a clear benefit limiting AAA growth, while data from ongoing clinical trials addressing the benefit of metformin on aneurysm progression are eagerly awaited. Recent preclinical studies have postulated new therapeutic targets and pharmacological strategies paving the way for the implementation of future clinical studies exploring these novel therapeutic strategies. This review summarises some of the most relevant clinical and preclinical studies in search of new therapeutic approaches for AAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lysyl Oxidase in Ectopic Cardiovascular Calcification, Role of Oxidative Stress

  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Vázquez-Sufuentes, Paula|||0009-0001-3369-9087
  • Garcia Redondo, Ana B.|||0000-0002-5815-3320
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Martínez-González, José|||0000-0002-3894-7166
Lysyl oxidase (LOX)-mediated extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease; however, this enzyme also induces oxidative stress. We addressed the contribution of LOX-dependent oxidative stress to cardiovascular calcification. LOX is upregulated in human-calcified atherosclerotic lesions and atheromas from atherosclerosis-challenged LOX transgenic mice (TgLOX) and colocalized with a marker of oxidative stress (8-oxo-deoxyguanosine) in vascular smooth muscle cells (VSMCs). Similarly, in calcific aortic valves, high LOX expression was detected in valvular interstitial cells (VICs) positive for 8-oxo-deoxyguanosine, while LOX and LOXL2 expression correlated with osteogenic markers (SPP1 and RUNX2) and NOX2. In human VICs, mito-TEMPO and TEMPOL attenuated the increase in superoxide anion levels and the mineralization induced by osteogenic media (OM). Likewise, in OM-exposed VICs, β-aminopropionitrile (a LOX inhibitor) ameliorated both oxidative stress and calcification. Gain- and loss-of-function approaches in VICs demonstrated that while LOX silencing negatively modulates oxidative stress and calcification induced by OM, lentiviral LOX overexpression exacerbated oxidative stress and VIC calcification, effects that were prevented by mito-TEMPO, TEMPOL, and β-aminopropionitrile. Our data indicate that LOX-induced oxidative stress participates in the procalcifying effects of LOX activity in ectopic cardiovascular calcification, and highlight the multifaceted role played by LOX isoenzymes in cardiovascular diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

PDE4 Phosphodiesterases in Cardiovascular Diseases, Key Pathophysiological Players and Potential Therapeutic Targets

  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Madsen, Leif Hove|||0000-0001-5493-3998
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
3',5'-cyclic adenosine monophosphate (cAMP) is a second messenger critically involved in the control of a myriad of processes with significant implications for vascular and cardiac cell function. The temporal and spatial compartmentalization of cAMP is governed by the activity of phosphodiesterases (PDEs), a superfamily of enzymes responsible for the hydrolysis of cyclic nucleotides. Through the fine-tuning of cAMP signaling, PDE4 enzymes could play an important role in cardiac hypertrophy and arrhythmogenesis, while it decisively influences vascular homeostasis through the control of vascular smooth muscle cell proliferation, migration, differentiation and contraction, as well as regulating endothelial permeability, angiogenesis, monocyte/macrophage activation and cardiomyocyte function. This review summarizes the current knowledge and recent advances in understanding the contribution of the PDE4 subfamily to cardiovascular function and underscores the intricate challenges associated with targeting PDE4 enzymes as a therapeutic strategy for the management of cardiovascular diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Upregulation of NOR-1 in calcified human vascular tissues, impact on osteogenic differentiation and calcification

  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Vázquez-Sufuentes, Paula|||0009-0001-3369-9087
  • Tauron, Manel|||0000-0002-5864-519X
  • Roselló-Díez, Elena|||0000-0003-2258-3246
  • Marín, Francisco|||0000-0001-7246-7708
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Martínez-González, José|||0000-0002-3894-7166
Cardiovascular calcification is a significant public health issue whose pathophysiology is not fully understood. NOR-1 regulates critical processes in cardiovascular remodeling, but its contribution to ectopic calcification is unknown. NOR-1 was overexpressed in human calcific aortic valves and calcified atherosclerotic lesions colocalizing with RUNX2, a factor essential for osteochondrogenic differentiation and calcification. NOR-1 and osteogenic markers were upregulated in calcifying human valvular interstitial cells (VICs) and human vascular smooth muscle cells (VSMCs). Gain- and loss-of-function approaches demonstrated that NOR-1 negatively modulates the expression of osteogenic genes relevant for the osteogenic transdifferentiation (RUNX2, IL-6, BMP2, and ALPL) and calcification of VICs. VSMCs from transgenic mice overexpressing NOR-1 in these cells (TgNOR-1) expressed lower basal levels of osteogenic genes (IL-6, BMP2, ALPL, OPN) than cells from WT littermates, and their upregulation by a high-phosphate osteogenic medium (OM) was completely prevented by NOR-1 transgenesis. Consistently, this was associated with a dramatic reduction in the calcification of both transgenic VSMCs and aortic rings from TgNOR-1 mice exposed to OM. Atherosclerosis and calcification were induce in mice by the administration of AAV-PCSK9 and a high-fat/high-cholesterol diet. Challenged-TgNOR-1 mice exhibited decreased vascular expression of osteogenic markers, and both less atherosclerotic burden (assessed in whole aorta and lesion size in aortic arch and brachiocephalic artery) and less vascular calcification (assessed either by near-infrared fluorescence imaging or histological analysis) than WT mice. Our data indicate that NOR-1 negatively modulates the expression of genes critically involved in the osteogenic differentiation of VICs and VSMCs, thereby restraining ectopic cardiovascular calcification.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lysyl oxidase-dependent extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease

  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Vázquez-Sufuentes, Paula|||0009-0001-3369-9087
  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Fernández-Celis, A.
  • Tauron, Manel|||0000-0002-5864-519X
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • López-Andrés, N.
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Martínez-González, José|||0000-0002-3894-7166
Extracellular matrix (ECM) is an active player in cardiovascular calcification (CVC), a major public health issue with an unmet need for effective therapies. Lysyl oxidase (LOX) conditions ECM biomechanical properties; thus, we hypothesized that LOX might impact on mineral deposition in calcific aortic valve disease (CAVD) and atherosclerosis. LOX was upregulated in calcified valves from two cohorts of CAVD patients. Strong LOX immunostaining was detected surrounding calcified foci in calcified human valves and atherosclerotic lesions colocalizing with RUNX2 on valvular interstitial cells (VICs) or vascular smooth muscle cells (VSMCs). Both LOX secretion and organized collagen deposition were enhanced in calcifying VICs exposed to osteogenic media. β-aminopropionitrile (BAPN), an inhibitor of LOX, attenuated collagen deposition and calcification. VICs seeded onto decellularized matrices from BAPN-treated VICs calcified less than cells cultured onto control scaffolds; instead, VICs exposed to conditioned media from cells over-expressing LOX or cultured onto LOX-crosslinked matrices calcified more. Atherosclerosis was induced in WT and transgenic mice that overexpress LOX in VSMC (TgLOX) by AAV-PCSK9D374Y injection and high-fat feeding. In atherosclerosis-challenged TgLOX mice both atherosclerosis burden and calcification assessed by near-infrared fluorescence (NIRF) imaging were higher than in WT mice. These animals also exhibited larger calcified areas in atherosclerotic lesions from aortic arches and brachiocephalic arteries. Moreover, LOX transgenesis exacerbated plaque inflammation, and increased VSMC cellularity, the rate of RUNX2-positive cells and both connective tissue content and collagen cross-linking. Our findings highlight the relevance of LOX in CVC and postulate this enzyme as a potential therapeutic target for CVC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting mitochondrial stress with Szeto-Schiller 31 prevents experimental abdominal aortic aneurysm, Crosstalk with endoplasmic reticulum stress

  • Navas Madroñal, Miquel|||0000-0003-2984-1471
  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Pérez, Belén|||0000-0001-5801-1704
  • Consegal, Marta|||0000-0002-9201-9117
  • Kassan, M.
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Galán, María|||0000-0002-4758-8388
Mitochondrial dysfunction and inflammation contribute to a myriad of cardiovascular diseases. Deleterious crosstalk of mitochondria and persistent endoplasmic reticulum (ER) stress triggers oxidative stress, which is involved in the development of vascular diseases. This study determined if inhibition of mitochondrial stress reduces aneurysm development in angiotensin II (Ang II)-infused apolipoprotein-E-deficient (ApoE) mice and its effect on ER stress. The mitochondria-targeted tetrapeptide, Szeto-Schiller 31 (SS31), ameliorated mitochondrial dysfunction and the enhanced expression of ER stress markers triggered by Ang II in ApoE mice, and limited plasmatic and vascular reactive oxygen species (ROS) levels. Interestingly, SS31 improved survival, reduced the incidence and severity of abdominal aortic aneurysm (AAA), and the Ang II-induced increase in aortic diameter as evaluated by ultrasonography, resembling the response triggered by the classic ER stress inhibitors tauroursodeoxycholic acid (TUDCA) and 4-phenylbutyrate (PBA). Disorganization of the extracellular matrix, increased expression of metalloproteinases and pro-inflammatory markers and infiltration of immune cells induced by Ang II in the abdominal aorta were effectively reduced by SS31 and ER inhibitors. Further, C/EBP homologous protein (CHOP) deficiency in ApoE mice attenuated Ang II-mediated increase in vascular diameter and incidence of AAA, suggesting its contribution to the favourable response induced by ER stress inhibition. Our data demonstrate that inhibition of mitochondrial stress by SS31 limits AAA formation and increases survival through a reduction of vascular remodelling, inflammation and ROS, and support that attenuation of ER stress contributes to the favourable response elicited by SS31.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting lysyl-oxidase (LOX) may facilitate intramural periarterial drainage for the treatment of Alzheimer's disease

  • Kelly, Louise|||0000-0002-5119-519X
  • Sharp, Matthew Macgregor|||0000-0002-6623-5078
  • Thomas, Isabelle
  • Brown, Christopher
  • Schrag, Matthew
  • Antunes, Lissa Ventura
  • Solopova, Elena|||0000-0001-5508-0368
  • Martínez-González, José Pablo|||0000-0002-5925-1010
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Carare, Roxana Octavia
Alzheimer's disease is the commonest form of dementia. It is likely that a lack of clearance of amyloid beta (Aβ) results in its accumulation in the parenchyma as Aβ oligomers and insoluble plaques, and within the walls of blood vessels as cerebral amyloid angiopathy (CAA). The drainage of Aβ along the basement membranes of blood vessels as intramural periarterial drainage (IPAD), could be improved if the driving force behind IPAD could be augmented, therefore reducing Aβ accumulation. There are alterations in the composition of the vascular basement membrane in Alzheimer's disease. Lysyl oxidase (LOX) is an enzyme involved in the remodelling of the extracellular matrix and its expression and function is altered in various disease states. The expression of LOX is increased in Alzheimer's disease, but it is unclear whether this is a contributory factor in the impairment of IPAD in Alzheimer's disease. The pharmacological inhibition of LOX may be a strategy to improve IPAD and reduce the accumulation of Aβ in the parenchyma and within the walls of blood vessels.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm, A potential therapeutic opportunity?

  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Varona, Saray|||0000-0002-7375-313X
  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Aguiló, Silvia|||0000-0003-0672-8388
  • Orriols, Mar
  • Martínez-Martínez, Ernesto
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647